Urgotul 99XX0071 Dressing, 5cm x 5cm, Pack of 10

Product Information

Mean time to complete epithelialisation was 9·6 and 11·9 days for the Urgotul ™ and TG sites respectively ( P < 0·05). The importance of pain reduction through dressing selection in routine wound management: the MAPP study. Flexible and highly conformable, can be used to cover irregular wounds or wounds in difficult locations and packing deep wounds.

UrgoTul - Urgo Healthcare Professionals UrgoTul - Urgo Healthcare Professionals

There was a total of 46 study wounds (24 partial thickness burns and 22 SSG donor sites), 23 dressed with Urgotul ™ and 23 dressed with TG. It was launched in 2000 by the Urgo laboratories in Dijon, France, as an improved alternative to both conventional and modern dressings characterised by its atraumatic and painless removal 4, 5.

UrgoClean is indicated for the treatment of exuding wounds in the desloughing phase (chronic wounds and acute wounds). UrgoStart should be changed every 2 to 4 days on average, and may be left in place for up to 7 days, depending on the exudate volume and the clinical condition of the wound. If clinical signs of local infection are noted, treatment can be changed to an antibacterial dressing dependent on clinical judgement. The aim is to create and maintain a local environment conducive to the healing process based on the concept of healing in a moist environment (3). Interest of a new dressing (UrgoTul) in the management of wounds in a pediatric setting: results from a european clinical study.

dressings without absorbent pad | Advanced wound Soft polymer dressings without absorbent pad | Advanced wound

C. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings.The importance of pain reduction through dressing selection in routine wound management: the MAPP study, Journal of Wound Care, 2004, Vol 13, No 10, 409-413. It is therefore recommended that the product be handled carefully, avoiding any contact with the coated surface or using sterile tongs. UrgoTul is a non-adhesive, non-occlusive interface, composed of a polyester mesh impregnated with hydrocolloid particles (carboxymethylcellulose), paraffin oil, petrolatum and polymers. The partial thickness burn wounds selected for comparison of dressing material were of similar burn depth as assessed by two blinded observers. The importance of pain reduction through dressing selection in routine wound manager the MAPP study.

Dressings Guide August 2020 update - Somerset CCG Quick Reference Dressings Guide August 2020 update - Somerset CCG

This is a prospective randomised control study with Institutional Review Board (IRB)‐approved study protocol. Participation in the study concluded upon reaching the study endpoint, which was complete healing of wounds.

Urgotul ™ is a lipido‐colloid wound dressing impregnated with hydrocolloid particles dispersed in a petroleum jelly matrix, wherein on contact with wound exudate, the hydrocolloid particles would absorb water, swell, and liquefy to form a moist gel layer, thereby maintaining a moist and warm environment at the same time preventing external bacterial colonisation. If clinical signs of local infection are noted, treatment can be changed to an antibacterial dressing, dependent on clinical judgement.

Urgotul™ in the treatment of partial thickness The use of Urgotul™ in the treatment of partial thickness

Acute wounds (burns, dermal abrasions, traumatic wounds, postoperative wounds), chronic wounds (pressure ulcers, diabetic foot ulcers) at the granulation and epithelialisation stage. Cover UrgoClean with a secondary dressing suitable for the location of the wound and level of exudate. This prospective clinical study was performed to evaluate a new class of lipido‐colloid dressings (Urgotul ™) in promoting healing and in reducing tissue adherence.

The use of paraffin‐impregnated gauze for burns and skin graft donor sites is commonly associated with wound adherence with consequent pain and trauma upon removal. In the event of an atypical ulcer demonstrating induration or excessive localised granulation, treatment with UrgoStart should only be started after having verified the absence of any ulcer deterioration, to prevent any delay in diagnosis.